Europe

Jan 13, 2010
By Pharmaceutical Executive Editors
Dr Kay Wardle of RSA examines the impact of short-term survival strategies on pre-clinical R&D organizations.
Dec 17, 2009
By Pharmaceutical Executive Editors
Quintiles' Jim Featherstone asks what the end of the blockbuster generation means for the sales operation?s business model and how pharma should react to the transition.
Nov 30, 2009
By Pharmaceutical Executive Editors
David Sun of InterbrandHealth looks at global pharma branding trends for 2010 and beyond.
Nov 02, 2009
Reflector reports on how the European pharma commitees and national associations are trying to shape the upcoming pharmaceutical package through informal
Aug 24, 2009
By Pharmaceutical Executive Editors
06 August 2009
Aug 18, 2009
By Pharmaceutical Executive Editors
18 August 2009
Aug 03, 2009
By Pharmaceutical Executive Editors
3 August 2009
Jul 31, 2009
By Pharmaceutical Executive Editors
31 July 2009
Jul 16, 2009
By Pharmaceutical Executive Editors
16 July 2009
Jul 08, 2009
By Pharmaceutical Executive Editors
08 July 2009
native1_300x100
lorem ipsum